The Saccbaromyces cerevisiae CDC46 protein accumulates in the nucleus of nondividing interphase cells. Soon after the cell has become committed to division, there is a rapid disappearance of CDC46 protein from the nucleus. This shift is not a consequence of variation in total CDC46 protein levels and is associated with DNA replication at the Gi-S boundary. We propose that the CDC46 protein, which is required for DNA replication, becomes mobilized quickly from the cytoplasm into the nucleus as mitosis is completed and persists there until the next round of division is initiated. This partitioning of proteins in a cell cycle-dependent manner illustrates a general means of regulating events that must occur only once in each cycle, such as DNA initiation.
The cell division cycle of all eukaryotic cells, whether a simple unicellular organism or from a mammalian tissue, requires a high degree of coordinated control. For instance, any attempts to separate incompletely replicated chromosomes is disastrous. The ability to keep order in the pathways that govern and carry out cell division, DNA duplication, and mitosis are thus of fundamental importance in all eukaryotes. Tremendous progress has been achieved because of the recent recognition that several cell division cycle [CDC] genes first identified in Saccbaromyces cerevisiae encode conserved elements required for global control of the cell cycle in all eukaryotes Nurse 1990) . One component, identified as CDC2 in Schizosaccharomyces pombe and CDC28 in S. cerevisiae, acts in combination with a set of cyclically synthesized proteins known as cyclins (Draeta et al. 1989; Richardson et al. 1989) . The cell division initiation, or "start," cascade has been conserved to such an extent that the controlling yeast and mammalian protein kinases are interchangeable (Beach et al. 1982; Lee and Nurse 1987; Wittenberg and Reed 1989) . Many of the signals that initiate the cycle, including nutritional status and the presence of intercellular factors, converge at the level of the CDC2/CDC28 kinase (Courchesne et al. 1989; Elion et al. 1990 ). The targets of this kinase are then mobilized to carry out the cell cycle cascade (Morenoand Nurse 1990) .
DNA replication is a central event that must be activated appropriately and in coordination with the rest of the cell cycle. Initiation at each replication origin is essential, but it must transpire only once per cycle. Despite the essential nature of this process and its importance in cell replication, some of the major constituents have been identified only recently (Burgers 1989; Stillman 1989) . Eukaryotic DNA replication is quite distinct from the process used by prokaryotes. As a simple eukaryotic cell, S. cerevisiae provides an excellent system to study DNA replication and the cell cycle. Furthermore, the sophisticated genetics available in this system make possible the isolation of previously unanticipated elements and provide a vehicle for observing physiological effects of known components. A few yeast mutants, altered in the cell division cycle, already have been useful in characterizing key components involved in DNA synthesis. The two major DNA polymerases are encoded by the CDC17 and CDC2 genes Sitney et al. 1989) , whereas DNA ligase is encoded by CDC9 (Johnston and Nasmyth 1978) .
We have identified several new members of the DNA replication machinery in S. cerevisiae. Two of these, cdc45 and cdc54, were isolated as cold-sensitive mutations that arrest with a single large bud . Extragenic suppressors have been isolated that permit normal growth of either cdc45 or cdc54 in the cold and also arrest with a large bud at 37°C. One gene, now called cdc46, yields efficient suppressors of both cdc45 and cdc54, but in an allele-specific manner. The cdc46 allele capable of suppressing cdc45 cannot suppress cdc54 and vice versa . This entire set of proteins is required for DNA replication, as judged by each of their mutant phenotypes (K. Hennessy, unpubl.) . We demonstrate here that the localization of CDC46 protein shifts between the nucleus and the cytoplasm as cells progress through the cell cycle. This localization change is independent of total protein levels and represents a novel form of regulation appropriate for events that must occur once, and only once, in the cell division cycle.
Results

DNA content of arrested cdc46 mutant cells
We have investigated w^hether CDC46 is required for either initiation or synthesis of genomic DNA. Samples from exponentially grov^ing diploid cultures of wild-type and homozygous cdc46-l mutant cells were stained with propidium iodide and the DNA content for each cell was determined by flow cytometry. In exponentially growing wild-type diploid cultures, 35% of the cells have unrephcated (2n) DNA content, and 65% exhibit a duplicated (4n) DNA content {Fig. lA). Mutant diploids homozygous for the temperature-sensitive cdc46-l allele display an unreplicated (2n) DNA content 3 hr after shift to 37°C, the nonpermissive temperature (Fig. IC) , suggesting that arrest has occurred at a point in the cell cycle before DNA synthesis. At an intermediate time (1.5 hr) after shift to 37°C, there is a substantial broad peak between 2n and 4n DNA content (Fig. IB) , suggesting that many of the cells have lagged in their DNA replication. There is no lag evident in either the wildtype culture at 37°C (Fig. lA) or the cdc46 culture at 2rC (not shown). By 3 hr, most of the cells that were in S phase at 1.5 hr have completed one round of DNA synthesis and cytokinesis only to subsequently arrest in the Wildtype 37°C 3hr
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RELATIVE DNA CONTENT Figure I . CDC46 is required for DNA replication. The DNA content of wild-type and cdc46 cells was determined by flow cytometry. Both homozygous cdc46-l or CDC46 diploid strains were shifted from a permissive temperature of 23°C to the nonpermissive temperature of 37°C. {B and C) Two time points taken from the same cdc46 culture. To the Tight of each graph, the percent of cells in the culture at each stage of the cell cycle (unbudded, small budded, or large budded) is indicated.
following cycle with a large bud and one-half the normal DNA content for a cell at this stage (Fig. IC) . Thus, cdc46 cells arrest with their DNA unreplicated, and we infer that DNA elongation is not blocked. More detailed interpretation of the DNA synthesis defect in cdc46 cells is given in the Discussion, below.
Among the characterized S. cerevisiae cell division mutants, cdc7, which is essential for DNA initiation, arrests with a phenotype similar to cdc46 mutants, an unreplicated genome in a cell that has produced a single large bud (Pringle and Hartwell 1981) . The fact that a cell morphology normally not present in growing populations accumulates in these mutant cells further supports the substantial body of evidence that the cell cycle involves the coordinated execution of several independent cycles and that cells can complete one portion of the cell cycle (cell growth) when another (DNA replication) is defective (Pringle and Hartwell 1981) .
The order of CDC46 gene function within the cell cycle
The unusual cell cycle arrest of large budded cells with an unreplicated genome suggests that CDC46 functions very early in the cell cycle, prior to or early in DNA synthesis. We have determined whether a cdc46 mutation will prevent cells from completing the cell cycle after a block in DNA elongation is removed, as would be expected for a block in DNA initiation (Hartwell 1976) . If the CDC46 gene product can execute its function before the majority of DNA replication is complete, then the essential function supplied by CDC46 should take place even if DNA replication is inhibited by hydroxyurea. A subsequent shift from hydroxyurea to the cdc46 nonpermissive temperature should not affect completion of the cell cycle in this case.
We arrested an exponentially growing cdc46-l culture with hydroxyurea in liquid medium and then substituted this cell cycle block (Slater 1973) with that of the cdc46-l cell cycle block by removing the hydroxyurea and placing the cells on an agar slab at the nonpermissive temperature for cdc46-l. Photographs were taken of the cells before and after this second arrest on the agar slab to assess the progression of each cell through the cell cycle. Table 1 summarizes the results of this experiment. Over 90% of the cells placed at the nonpermissive temperature (37°C) can recover from the hydroxyureainduced cell cycle block, complete one cell cycle, and arrest division during the second cell cycle. In addition to transferring the hydroxyurea-arrested cells to 37°C, some were placed at the permissive temperature for cdc46 to confirm that the hydroxyurea-induced cell cycle block is reversible and not lethal. A second aliquot of cells was placed on solid medium containing hydroxyurea to show that the hydroxyurea block is complete throughout the experiment. Consequently, we surmise that CDC46 functions very early in the cell cycle, before DNA elongation. This is consistent with the early execution of the CDC46 function in the general unsynchronized cell cycle (D. Moir and D. Botstein, unpubl) . "All incubations with hydroxyurea were at 26°C. Where a temperature is indicated, incubation was in the absence of hydroxyurea (HU).
Identification of the CDC46 gene product
We cloned the CDC46 gene and localized the wild-type protein using antibodies generated against a CDC46-trpE bacterial fusion protein. As described in Materials and methods, the gene was cloned by transforming a cdc46-l mutant strain with a 5. cerevisiae DNA library in the yeast vector YCp50, which carries a yeast centromere and replication origin for plasmid maintenance (Rose et al. 1987) . One complementing plasmid, pRB541, has an insert of 15.6 kb capable of rescuing the temperature-sensitive lethality at 37°C. The portion of pRB541 responsible for complementation was localized further by eliminating this activity with mini-TnlO-lacZ-kan^-URA3 (TniO-LUK) transpositions (Huisman et al. 1987) . All plasmid derivatives with transposon insertions within or immediately adjacent to a 1.1-kb BamHl fragment (Fig. 2) failed to complement, indicating that this fragment is intemal to the gene. This internal BamHl fragment was subsequently used for both gene disruption and bacterial expression experiments.
To establish that the complementing plasmid pRB541 carries the CDC46 gene, we constructed strains with a disruption at the 1.1-kb BamHl fragment. The 1.1-kb fragment was subcloned into the yeast-integrating plasmid YIp5 and used to transform a yeast diploid strain, DBY5450. Because this strain is heterozygous for the cdc46-l mutation, a disruption of the wild-type gene should unmask the temperature-sensitive phenotype if the 1.1-kb fragment is exclusively CDC46-coding sequence. Half of the transformants recovered were temperature sensitive, confirming that the mutation lies within the gene disrupted by the 1.1-kb BamHl fragment insertion. After sporulation and tetrad dissection of diploid transformants with temperature-sensitive (DBY4921) or wild-type (DBY4922) phenotypes, the viability of the spores was assessed. Only half of the spores were viable, and as expected, all of these (112 of 112) were uracil auxotrophs and able to grow at 37°C, indicating that the integrated plasmid carrying the URA3 gene was completely linked to the lethality and that the temperature-sensitive copy of cdc46 has been disrupted. When the temperature-sensitive diploid was dissected, all of the viable spores were temperature sensitive, as well as Ura~. Similar experiments with a strain that has the plasmid integrated into the URA3 locus (DBY5449) show that the plasmid itself has no effect on spore viability. Thus, CDC46 is an essential gene and the cloned 1.1-kb BamHl fragment carries an intemal portion of this gene, because it integrates exclusively at, and inactivates, the CDC46 locus.
The same 1.1-kb BamHl fragment was used to construct a CDC46-trpE fusion expression protein that we used to elicit rabbit antibodies against the CDC46 protein (henceforth, CDC46p). The trpE hybrid proteins are easily enriched due to their insolubility and were purified further by SDS-PAGE. As described in Materials and methods, antibodies from two rabbits were affinity purified independently on a tTpE-CDC46 column. After two consecutive affinity purifications, the antibodies react with a single 95-kD protein band present in immimoblotted S. cerevisiae extracts (not shown, but see Fig. 7 , below). Antibodies purified independently from both rabbits react with the same band on SDS-PAGE, identifying the CDC46 product as a 95-kD protein.
Subcellular localization of CDC46
Affinity-purified antibodies directed against CDC46p applied to a fixed exponential culture of wild-type yeast cells react with nuclei in a cell cycle-dependent manner as observed by immunofluorescence (Figs. 3 and 4) . In the early stages of the cell cycle, prior to formation of a daughter cell, CDC46p is observed predominantly in the nucleus, although faint cytoplasmic staining is evident. Remarkably, once the bud has formed, the nuclear staining disappears. Nuclear staining reappears later in the cell cycle, in cells that have completed daughter cell growth and chromosome division. It should be stressed that all cells at each particular stage of the early cell cycle appear to stain in the same way, for example, nuclear staining in unbudded cells and cytoplasmic staining in small budded cells. However, not all the large budded, postmitotic cells have nuclear CDC46p staining. There are two classes of cells with this same gross physical morphology that can be differentiated by the localization of CDC46p. Because large budded cells often have an extended nucleus, we can see in them that staining of CDC46p is associated specifically with the DAPI staining region rather than being distributed landmarks to the steps prior to DNA synthesis: cdc28 defines the start point of the cell cycle (mutant cells arrest without a bud after shift to nonpermissive temperature); cdc4 and cdc7 define later steps in the cycle cells, and mutant cells arrest with buds at the nonpermissive temperature (Pringle and Hartwell 1981) . The three gene functions are required in the order cdc28, cdc4, and cdc7 (Hereford and Hartwell 1974) . We used mutants in these genes to define, at higher resolution, the stage of the cell cycle where cdc46 nuclear staining disappears.
In each case, haploid mutant cells were shifted to their nonpermissive temperature for a period long enough to arrest most of the cells with the morphology typical of that mutation. Immunolocalization with the affinitypurified anti-CDC46p antibodies showed that nuclei in arrested cells carrying cdc28 and cdc4 displayed nuclear staining while cdc7 cells showed an intermediate phenotype, with no cells showing strong nuclear staining and most cells showing weak cytoplasmic staining ( Fig. throughout the entire nucleus. This is the kind of behavior that might be expected if CDC46p is a DNA-associated protein.
To clarify the basis for two classes of large budded cells, the timing of CDC46 reappearance was studied relative to mitosis. The mitotic spindle was observed by staining cells with rhodamine-labeled anti-tubulin antibody in addition to FITC-labeled anti-CDC46 antibody and DAPI (Fig. 4 ). Cells were then photographed and grouped into one of four categories based on cell and spindle morphology: (1) unbudded, (2) small budded, (3) large budded with long spindle, or (4) large budded with a disassembled spindle. The fraction of cells and their staining pattern for each of these four categories is shown in Figure 5 as part of a schematic representation that can account for CDC46 localization changes. Postmitotic cells, which have not yet completed cytokmesis, show nuclear CDC46p staining, whereas budded cells at earlier points in the cell cycle display no nuclear staining.
With the division of the large budded cells into two types based on the spindle morphology, we observe a close correlation between position in the cell cycle and presence of CDC46p staining in either nucleus or cytoplasm. We observe few, if any, cells showing intermediate staining in these unsynchronized cultures, implying that appearance of CDC46p in the nucleus during the last stages of division and the disappearance coincident with bud emergence are both rapid processes. This result suggests that the timing of the appearance and disappearance of CDC46p could be determined more exactly using cell cycle mutants. By using other cell division cycle mutants, the steps leading up to bud emergence and DNA replication can be separated from other concurrent processes, allowing the effect of each on CDC46 localization to be ascertained.
Localization of CDC46 product in arrested cells
Three S. cerevisiae cell division cycle mutants serve as only way to follow this step in the cell cycle.
Localization by cell fractionation
Immunolocalization studies represent only one way in which the presence of a protein can be followed. To confirm our results by a different method, we isolated nuclei from cells at various stages of the cell cycle and assayed the relative CDC46p content by immunoblotting analysis. Wild-type cells were arrested at either of two well-defined stages in Gj phase with a-factor or in M phase (mitosis) with a cold-sensitive p-tubulin mutant, tub2-104. These cultures were then lysed and fractionated into a crude "nuclear" pellet and a soluble "cytoplasmic" fraction by centrifugation. DAPI staining of each fraction was used to assess the presence of nuclei. Samples of each fraction were then adjusted so that the same cell equivalent was present, resulting in much less total protein in the fractions containing nuclei. Figure 7 shows that a-factor-arrested cells accumulate CDC46p in the nuclear fraction. In contrast, when cells are arrested in mitosis with a (i-tubulin defect, most of the CDC46p is found in the cytoplasmic fraction. This confirms CDC46 localization based on immunolocalization by microscopy. 6). From these results we can infer that the disappearance of CDC46p antigen from the nucleus occurs at some time after the execution points of cdc4, and possibly near the execution point of cdc7.
In the same way we tested many mutations that define later steps in the cell cycle, including some that affect DNA synthesis {cdc9, cdc2, and cdclJ], mitosis [tub2, cdcl6, cdc20, and cdc31], or late mitotic events {cdcl4, cdclS, and cdc5] (Pringle et al. 1981 ). All of these displayed cytoplasmic staining in arrested cells and no staining in the nucleus. From these results we can infer that the disappearance of CDC46p antigen occurs before the execution point of cdcl7, that is, between cdc4 and cdcll, possibly at about the same time as cdc7. It is worth noting here that CDCl 7 encodes one of the major nuclear DNA polymerases of yeast (Carson 1987; Budd et al. 1989 ). The studies with these mutants indicate that the disappearance of CDC46p antigen from the nucleus is not associated with bud formation or mitosis. However, there is a correlation between loss of CDC46p from the nucleus and the beginning of S phase, making attractive the idea that CDC46p disappearance is coincident with the initiation of DNA synthesis. In normal wild-type cells, this event occurs at the time of bud emergence just when the CDC46p staining disappears from the nucleus (Fangman et al. 1981) .
None of the mutations we tested show nuclear staining like the class of large budded cells that have broken down their spindle and show nuclear CDC46p antigen. The current set of cdc mutations affecting late events apparently contains none that separates these two classes. Staining with anti-CDC46p antibody (along with careful examination of the spindle) remains the
Total levels of CDC46p
Cyclical expression and degradation of the CDC46 product could explain the observed staining patterns, that is, the CDC46 product could be a cyclin-like protein (Minshull et al. 1989 ). We examined the total level of CDC46 in a synchronized population of wild-type yeast cells through two cell cycles after removing an afactor block. Reasonably good synchrony was achieved in this experiment: Over 85% of the cells had a long mitotic spindle 80 min after removal of the a-factor. Immunoblotted protein samples taken from the synchronized culture at 10-min intervals were reacted with anti-DNA Synthesis Figure 6 . Localization of the CDC46 product in cells arrested at different points in the cell cycle. Affinity-purified antibodies to CDC46 were reacted with populations of mutant S. cerevisiae cells, as described in Fig. 4 , that have been arrested at points in the cell cycle defined by the indicated cdc mutants. The results are shown schematically here. Mutations in start, as defined by cdc28, give a strong nuclear staining and apparently accumulate the CDC46 product in the nucleus. Unlike the wild-type populations, CDC46 nuclear staining is present in budded cells that have been arrested with a cdc4 defect (although shown here as a single large bud, cdc4 continues to bud in the arrested state). The last mutant ordered prior to DNA replication is cdc7, which shows a CDC46 nuclear localization. All other cdc mutants observed, including cdc2, cdc9, cdcl6, cdc31, cdc5, cdcl4 , and tub2, show cytoplasmic accumulation of CDC46 product, as evidenced by immunofluorescence. Figure 7 . CDC46 fractionates in different compartments at distmct points of the cell cycle. Two cultures of arrested S. cerevisiae were divided into crude nuclear and cytoplasmic fractions. One culture was arrested with a-factor, a point in the cell cycle that shows prominent nuclear staining. The second carries a cold-sensitive mutation in the p-tubulin gene and arrests with nuclear exclusion of CDC46 staining. Shown is a Western blot of these fractions, as well as a sample of the lysate prior to fractionation for each arrested culture that has been reacted with anti-CDC46 sera. Each of the samples has been normalized to have the same number of cell equivalents in each lane.
CDC46
, as v^ell as anti-p-tubulin and anti-actin antibodies, to calibrate for the amount of protein loaded in each lane (Fig. 8) . Although there are discernible fluctuations (quantitatively about tv^ofold) in the amount of CDC46p, the changes relative to actin are small except for the initial increase after the removal of a-factor. Thus, the differences seen in localization are not simply a reflection of degradation of a large fraction of the total CDC46p in the cell.
To control for the levels of mRNA on each lane, the blot also was hybridized to a probe specific for the actin [ACTl] gene. Another probe for the histone H2B {HTB2) transcript, which is transiently expressed during S phase, indicates the period of DNA replication and testifies to the degree of synchrony within the culture. Normalization to these bands shows that the increase in CDC46 transcript is cell cycle specific and indicates that although there are no large fluctuations in the protein levels once the cell cycle has commenced, the transcript is nevertheless regulated and most of the synthesis of CDC46 mRNA occurs in small budded cells.
Protein levels of CDC46 in mutant cells
cdc46 mutant cells lack nuclear CDC46p staining at the nonpermissive temperature. Because this result suggests that the mutant defect is due to a lack of CDC46p in the nuclear compartment, we looked at the total levels of CDC46p in cells held at permissive or restrictive temperatures (Fig. 10) . The level of CDC46p is consistently reduced to one-half the amount of wild type at the nonpermissive temperature, whereas the levels under permissive conditions resemble those in wild-type cells.
(3(3&(3&(5@(S
100% -°2
SS §SSRS^8SSSi
Time ( CDC46 mRNA is differentially expressed during the cell cycle Despite the evidence that cyclical synthesis and degradation cannot alone account for the cyclical changes in CDC46p localization, we undertook a study of the levels of CDC46 mRNA through the cell cycle. We identified a single transcript of 2.3 kb in exponentially growing cells (Fig. 9, lane 1) . To determine whether CDC46 mRNA levels change during the cell cycle, we synchronized a DBY1826 culture using a-factor arrest. After 3 hr of incubation in the presence of a-factor, the CDC46 transcript is still present (Fig. 9, lane 2) . Thirty minutes after release from a-factor arrest, the mRNA level has decreased eightfold (Fig. 9, lane 4) . By 60 min, the level has increased back to that seen in the exponential culture.
-P-Tubulin
• -Actin Figure 8 . CDC46 is not a true cyclin. A wild-type culture of S. cerevisiae was synchronized with a-factor. Protein samples were taken prior to, and every 10 min after, release into fresh media.
[Bottom] An immunoblot of those samples that have been reacted with antibodies to CDC46, (3-tubulin, and actin. The graph indicates the percent of cells in the culture that are budded and those in mitosis at each of the times that samples were taken.
[Top] The type of cell morphology and whether CDC46p localizes to the nucleus. 3-10) . The Northern blot was probed sequentially with HTB2-, CDC46-, and ACTlspecific probes. HTB2 mRNA is -0.6 kb, ACTl mRNA is 1.4 kb, and CDC46 mRNA is estimated to be 2.3 kb. The graph represents bud counts. At least 200 cells were scored for each time point. This is true for three different alleles of cdc46, and the change in levels independently corroborates that the 95-kD protein is CDC46p. We infer that overall depletion of CDC46p in the mutant cells results in both the cell cycle defect and the failure to see nuclear staining.
Discussion
CDC46 function is required for DNA synthesis
A particularly useful characteristic of budding yeast is the ease with v/hich many defects in the cell cycle can be identified by their arrest phenotype and readily distinguished from general metabolism defects. Conditional mutations in either DNA polymerase or tubulin, for example, result in a large bud attached to the mother cell at the restrictive temperature, giving rise to a grow^ing, dumbbell-shaped cell. How^ever, because bbth S-phase and M-phase cell division cycle [cdc] defects give rise to this same large bud arrest phenotype, it has been difficult to distinguish betv^een mutations in these two processes. The application of flow cytometry (Hutter and Eipel 1978) now permits quick determinations of the DNA content in a cell cycle-arrested yeast cell. Flow cytometry surveys the gross level of DNA in each cell (including that residing in the mitochondria) and in this case, has unambiguously identified a defect in S phase, the DNA replication portion of the cell cycle, in cdc46 mutants. The lack of significant DNA synthesis in the arrested cdc46 mutant is consistent with the shift in CDC46 localization that occurs early in S phase.
DNA replication proceeds in two stages: initiation of the replication fork and elongation of the new strands. Because eukaryotic DNA synthesis is initiated at multiple origins, it is impossible to distinguish, based solely on the DNA content, between a cell with only half of its replication origins completely elongated and another cell that has every origin only half-elongated. As a result, a partial defect in either initiation or elongation can lead to an accumulation of cells with a DNA content intermediate between that of diploid cells with unreplicated (2n) or fully replicated (4n) chromosomes. So, while the peak of cdc46 cells with a DNA content between 2n and 4n (Fig. IB) attests unambiguously to an S phase defect, this "lag" in S phase does not distinguish incomplete initiation from an elongation failure. In the end, the cells complete DNA elongation and cytokinesis, as the final cdc46 arrest state is a large budded cell with an unreplicated genome.
Once cdc46 cells enter into S phase, they can continue on through the cell cycle to finally arrest in Gi, a phenotype more compatible with a DNA initiation defect than a failure in DNA elongation. The abihty of CDC46 to execute its function during a hydroxyurea-induced DNA elongation block implies that CDC46p is required before DNA elongation, at the initiation step.
Possible function of cell cycle-dependent nuclear localization of CDC46p
Recently, combined biochemical and genetic approaches have led to substantial progress toward understanding cell cycle control (Lewin 1990; Nurse 1990 ). The regulation of CDC46 function provides an example of a novel and potentially general regulatory mechanism, one in which subcellular localization supplements transcriptional and translational controls. In the present case, we have shown that the function of CDC46 is required in the initial steps of DNA synthesis. The pattern and timing of CDC46p localization are consistent with this result, as antigen disappears from the nucleus at exactly the time that the function is required. It seems likely that the properties that make it possible for CDC46p to be in the nucleus at the appropriate time are representative of the regulatory stringency required for ordered events in the cell cycle to occur in the correct sequence. Thus, we see that the protein is synthesized a considerable time before it is required but not present at its putative point of action until the right moment.
The possibility that the cell cycle-dependent localization of CDC46 has an important regulatory function must be considered. We suggest that it might play a regulatory role that bridges and couples two cell cycles: An event late in mitosis (entry into the nucleus) triggers an event (initiation of DNA replication) that must occur in the next cycle. The disappearance from the nucleus thereafter guarantees that there is no residual function to initiate another round accidently. Blow and Laskey (1988) have provided a model that describes a regulatory pathway that is needed to explain how the initiation of DNA replication occurs once and only once at each of the multiple origins within a eukaryotic nucleus. The cychc nuclear localization of CDC46 and the essential role that CDC46 plays in DNA replication is consistent with such a model.
It should be noted that other proteins have functions that might also be required in the nucleus just once in the cell cycle. Preliminary results concerning SWI5, a gene involved in the genetic events behind mating-type switching in yeast (which occurs in the nucleus at about the time of initiation of DNA replication; Nasmyth et al. 1987) suggest cyclical localization of the gene product entirely analogous to the cyclical localization found for CDC46p (Lewin 1990; Nasmyth et al. 1990) .
Possible mechanisms for cell cycle-dependent changes in localization of CDC46 product
Before attempting an explanation of the nuclear appearance and disappearance phenomena described for CDC46p antigen, it is worth recapitulating the basic facts that act as boundary conditions to any model. First, we found little fluctuation in overall levels of antigen in the cell. While the total amount increases as the cells come out of a-factor arrest, the increase is threefold and does not correlate with the changes seen by immunofluorescence. More specifically, while the levels of total protein are rising at 20 min (Fig. 8) , there is little or no nuclear staining in wild-type cells during this portion of the cell cycle. After this initial rise, the levels of total CDC46p remain relatively constant well into the second cell cycle. The lack of fluctuation in protein levels essentially rules out a cyclin-like mechanism for CDC46, in which levels change rapidly and go through great extremes (for review, see Minshull et al. 1989) .
Second, we found that synthesis of the protein is likely to be cyclical, as judged from the cyclical variation in the level of CDC46 mRNA, which is most abundant late in mitosis. These variations are timed in such a way that they alone cannot account for the variation seen in nuclear staining. Any model for these phenomena will have to reconcile the generally constant level of total antigen with the clear cyclical variation in the level of mRNA.
Third, the changes in localization observed by immunofluorescence are consistent with the results of fractionation experiments, thus making relatively unlikely localization-specific changes in epitope as opposed to changes in abundance of the protein. When crude fractionations are done on yeast cells arrested in Gi (with a-factor) or M (with tub2-104 mutation), there is a difference in localization: CDC46p is present in the nucleus in the former case and in the cytoplasm in the latter. This observation agrees perfectly with the immunofluorescence results; a-factor-arrested cells stain the nucleus brightly and show little diffuse cytoplasmic staining, whereas the tubulin-arrested cells display cytoplasmic staining and nuclear exclusion. Because there is an overall increase of CDC46p in tut>2-arrested cells, it may be more appropriate to conclude that the site of CDC46 accumulation rather than its localization has changed. Because both types of arrest give rise to cells that show strong immunofluorescent staining, albeit in different compartments, it is doubtful that the polyclonal antibodies from two rabbits used in these experiments are preferentially recognizing a modifiable epitope on CDC46 but, rather, are accurately indicating the location of CDC46p.
In view of the complex regulation of CDC46 at many levels, any model that we make to account for the cyclical localization of CDC46p will necessarily be speculative. We are making the reasonable assumption that CDC46 must enter the nuclear compartment for DNA replication to proceed.
One model to explain the CDC46 staining pattern envisions that the actual level of CDC46p remains the same through the cell cycle and that the protein cycles back and forth between the cytoplasm and the nucleus. At present we cannot rule this model out, although to reconcile the cyclical fluctuation of mRNA with the relatively very constant total level of protein, one would have to envision either cyclical degradation coincident with synthesis or some kind of mechanism limiting translation of the cyclically made mRNA. Detailed kinetic analysis of CDC46 synthesis at the protein level will be required to shed more light on these issues.
We prefer a second model designed to account for the complex regulatory program observed. In this model, (1) CDC46p is briefly synthesized late in the cell cycle, as suggested by our RNA level measurements, and accu-mulates in the cytoplasm,-(2) CDC46p is specifically translocated into the nucleus immediately after anaphase, by a process possibly involving a post-translational modification such as protein phosphorylation; (3) translocation is essentially complete before cells pass start, the beginning of the cell cycle; and (4) the CDC46p in the nucleus, having performed its essential function, presumably in initiation of DNA replication, is degraded during the S phase.
We note several features of our results that support different aspects of this model. First, the notion that CDC46p is made and accumulates in the cytoplasm is supported by the observation (both by immunofluorescence and by fractionation) that high levels of CDC46p accumulate in the cytoplasm in arrested tub2 cells. This result, more than any other feature, suggests to us that translocation into the nucleus is not simply a concentration-dependent process. Second, the rapid, specific translocation step is supported by our observation that we found two classes of large budded cells with nuclei that had already been separated: those with CDC46p mainly in the cytoplasm and those with the protein apparently entirely in the nucleus. This stage of the cell cycle is very short, suggesting a rapid process. Modification of the protein seems like an attractive mechanism to account for the apparent rapidity and completeness of the translocation. Third, the swift degradation of the nuclear CDC46p is supported by the rapidity of disappearance of antigen from the nucleus at just the time that synthetic rates (as estimated from the mRNA levels) should be maximal.
In conclusion, we believe that in CDC46, we have identified an essential function that must act just once during the cell cycle. The function of CDC46 appears to be some aspect of initiation of DNA replication and probably takes place in the nucleus. We hypothesize that the cyclical nuclear localization of the protein guarantees that the function will be carried out only at the correct point in the cell cycle, because the protein is not present in the nucleus at other, inappropriate times. It is likely that CDC46 is only one of a number of genes (SWI5 may be another) with nuclear functions that are prevented from acting at the wrong time by being admitted to the nucleus only at the right time. It remains to be discovered whether all such genes share the same mechanism of cyclical nuclear localization.
Materials and methods
Strains and media
Yeast media and genetic manipulations have been described by Sherman et al. (1974) . S. cerevisiae strains used in this study are listed in Table 2 . The cold-sensitive cdc mutant, CC30 , which arrests with a large bud at 18°C, has been named cdc54-l. The cdc46-l allele is described as the rA18-95 isolate . Bacterial media were as described in Davis et al. (1980) . The Escherichia coh strain that was used for routine cloning, HBlOl (DB1142), has the genotype: leu~ pro~ thr~ hsdR-hsdM~ recA'.
Isolation of the cdc46 gene
A YCp50 library of S. cerevisiae DNA (pRB236; Rose et al. 19871 was used to transform (Ito et al. 1983; Kuo and Campbell 1983) a cdc46-l, ura3-52 strain, DBY2028. Transformants were selected on minimal plates lacking uracil at 26°C and for complementation of the cdc46 defect at 37°C. Plasmid DNA from pRB541 was purified from a complementing clone (Hoffman and Winston 1987) and was used to transform the £. coh strain HBIOI.
Tnl(y-LUK mapping
Because the TnlO-lacZ-kan'^-URA3 (TniO-LUK; Huisman et al. 1987 ) carries the URA3 gene as its yeast marker, it was necessary to replace the YCp50 URA3 gene with a LEU2 marker. This was done in vivo by site-specific recombination in yeast . pRB541 was linearized by digestion with the restriction enzyme Smal, which only cuts pRB541 within URA3, and mixed with the YEp21 Sphl-Pvull fragment that holds the LEU2 gene (Botstein et al. 1979) prior to transformation of the yeast DBY2028. DNA from Leu + , Ura" yeast transformants was isolated, and plasmids were recovered by transformation of the £. coh strain DB1328. Transpositions were carried out as described (Huisman et al. 1987) , and DNA purified from pooled Kan'^ colonies was used to transform the yeast strain DBY2028. Uracil prototrophic yeast strains were screened for the ability to complement the cdc46 defect at 37°C. The location of each transposon was subsequently determined by restriction enzyme analysis of plasmids recovered from £. coh.
Disruption of the CDC46 gene
The 1.1-kb BamHl fragment from pRB541 ( Fig. 2 ) was cut as a band from a SeaPlaque agarose gel (FMC; Rockland, ME) and ligated into the BamHl site of the yeast integration plasmid YIp5 (Botstein et al. 1979; Struhl 1985) . After bacterial amplihcation, the resulting plasmid was linearized with either Xbal (which cuts within the 1.1-kb insert) or Ncol (which cuts in the plasmid URA3 gene) and used to transform the diploid yeast strain DBY5450. Transformant strains with and without temperature-sensitive phenotypes were recovered, and their meiotic products.were dissected. The presence of the disruption was detected in the viable meiotic progeny, and that of the diploid parents was detected by DNA hybridization using a ^^P-hbeled CDC46 1.1-kb BamHl fragment as probe.
Bacterial expression
The same 1.1-kb BamHl fragment from pRB541 that was used for disruptions was ligated into the series of bacterial expression vectors: pATHl, pATHlO, and pATHU. Each of these three vectors has a BamHl site in a different reading frame of the trpE gene (Dieckmann and Tzagoloff 1985) . Proteins from the six RRl bacterial clones (each carrying one of the three vectors with the insert in one of two orientations) were analyzed by SDS-PAGE and immunoblotted with anti-£rp£ antibodies (Harlow and Lane 1988) . One of these, pRB1351, produced a fusion protein that was isolated as an insoluble pellet after lysozyme, Nonidet P-40 (NP-40) lysis. This fraction was purified further by SDS-PAGE, and the gel containing the fusion protein was injected into rabbits with Freund's adjuvant (Harlow and Lane 1988) . Thomas (1985) this study this study
Antibody purification
Two milligrams of gel-purified CDC46-trpE fusion protein was electroeluted (ISCO electrophoretic sample concentrator; Lmcoln, NE) and coupled to a CNBr-activated Sepharose-4B (Pharmacia; Piscataway, NJ) matrix. Coupling was carried out as suggested by the manufacturer, except 0.1% SDS was added to the reaction to solubilize the fusion protein. A column with coupled trpE protein was prepared similarly. The trpE protem reactivity was removed from crude rabbit serum by incubatmg 10 ml of serum with 2 ml of packed, boiled, and sonicated trpEexpressing bacteria. This mixture was clarified by spinning at 30,000g for 30 min, and the process was repeated again. Residual trpE reactive antibodies were removed by passing the purified serum over a trpE affinity column. The remaining antibodies were then loaded onto the CDC46-tTpE fusion affinity column and eluted with 4.5 M MgClj and 10 mM Tris (pH 7.0), followed by 100 mM glycine-HCl (pH 2.5) (Bio-Rad bulletin 1099; Pringle et al. 1989) . These highly purified antibodies were used in all subsequent experiments except for those using the cell fractionation samples (see below). Finally, serum from a second rabbit was purified as described above to allow comparison of the two preparations.
Immunofluorescence
Using the protocol of Kilmartin and Adams ( 1984; Pringle et al. 1989) , cells were fixed in growth media with 3.7% formaldehyde for 1 hr, and the walls were digested with 100 |xg/ml Zymolyase lOOT (ICN; Lisle, IL) and dried onto polylysine-coated multiwell slides (Polysciencc; Warnington, PA). After methanol-acetone fixation, the slides were rehydrated m phosphate-buffered saline (PBS) and blocked with 100 (i.g/ml bovine serum albumin (BSA) in PBS. The primary antibodies were YOLl/34, anti-yeast/anti-tubulin, diluted Viso (Kilmartin et al. 1982) or affinity-purified rabbit anti-CDC46-£rp£ fusion protein. Both were incubated with fixed cells for 2 hr at 22°C and washed with PBS at least four times. The secondary antibodies were fluorescein-labeled goat anti-rat IgG and rhodamine-labeled goat anti-rabbit IgG (Cappel, Malverne, PA), diluted ' /300 in PBS, and each was reacted two times in an alternating cycle resulting in a greatly amplified signal. Fluorescein-labeled goat anti-rat IgG was prereacted with Sepharose-rabbit IgG, and rhodamine-labeled goat anti-rabbit IgG was prereacted with Sepharose-rat IgG to remove any cross-reactions. After each incubation with cells for 1 hr at 22°C, the slides were washed at least four times with PBS. The cell DNA was stained with 1 mg/ml of DAPl (4',6'-diamidino-2-phenyhndole) in PBS for 5 mm, followed by at least four washes of PBS.
Cell fractionation
Fractionation was carried out using the protocol of Goto and Wang (Goto et al. 1984) . Arrested yeast cultures were washed, and the walls were digested with 100 |xg/ml zymolyase T100 in a mixture of 1 M sorbitol, 20 mM potassium phosphate (pH 6.8), 0.5 mM CaCl^, and 0.5% p-mercaptoethanol. The spheroplasts were spun through a sorbitol step gradient at 2500g for 5 min to remove proteases, resuspended in a mixture of 18% Ficoll (Pharmacia; Piscataway, NJ), 20 mM potassium phosphate (pH 6.8), 0.5 mM CaCl^ and 0.5% p-mercaptoethanol, and 1 mM PMSF and lysed by Dounce homogenization. Unlysed cells were removed by centrifugation at 4500g for 5 min. The lysate ("total" fraction) was spun at 30,000g for 30 min to pellet a crude nuclear fraction and leave a supernatant, which is the cytoplasmic fraction. All fractions from each fractionation experiment were normalized to the same volume to allow comparison of the three fractions on a per cell basis. DAPI-stained nuclei were detected by observation through an epifluorescence microscope with differential interference contrast optics.
Determination of yeast cell DNA content
Whole diploid cells of yeast strains KH195 and KH208 were prepared for the fluorescence-activated cell sorter by staining with propidium iodide (Hutter et al. 1978) . Briefly, cells were ethanol-fixed and treated overnight with 0.1% RNase, followed by 5 mg/ml proteinase K prior to incubation in 5 mg/ml propidium iodide. The propidium iodide was removed immediately prior to running each sample through a Cytofluorograph System (Ortho Diagnostic Systems, Westwood, MA).
Functional ordering
The methods for arresting the cell cycle and shifting from one cell cycle inhibitor to another are described in detail elsewhere . After arresting an exponentially growing cdc46-l culture (DBY1104) at the beginning of the cell cycle with 2 (xg/nil a-factor (Sigma), the a-factor was removed and the cells were washed. They were then sonicated briefly to remove clumps and incubated in fresh YEPD with 0.1 M hydroxyurea for 150 min. The second condition was imposed by spotting the hydroxyurea-arrested cells on an agar slab after a brief wash in warm media. The position of each cell in the cell cycle was recorded by photography before and after the second incubation on the agar slab.
RNA analysis
Yeast strain DBY1826 was synchronized by a-factor arrest. Cells were grown in YEPD (pH 4.0) to 0.8 x 10* cells/ml at 30°C. Trial experiments determined that 2.5 |xg/ml of a-factor (Sigma) was the least amount needed to assure arrest. After 3 hr of incubation in the presence of a-factor, the culture was rinsed twice with water and resuspended in YEPD (pH 4.0), and 10-ml aliquots were removed at each time point for RNA extraction. In addition, aliquots were saved in 3.7% formaldehyde, sonicated, and scored microscopically for bud counts. Total yeast RNA was isolated as described (Carlson and Botstein 1982) . For RNA blots and hybridization analysis, we followed the instructions for Genescreen Plus (New England Nuclear), using the dextran sulfate method. DNA fragments used as probes were as follows: for HTB2, a 1.3-kb Hindlll restriction fragment containing the 3' region of the HTB2 gene (Hereford et al. 1979) ; for ACTl, a 1.6-kb Hindlll-BamHl restriction fragment internal to the coding sequence (Ng and Abelson 1980) ; for CDC46, a 1.1-kb BamHl internal restriction fragment (see Fig. 2 ). Labeled DNA probes were prepared by random oligonucleotide labeling (Feinberg and Vogelstein 1983) in the presence of I^^PjdCTP (3000 Ci/mmole, New England Nuclear).
